Literature DB >> 17049180

Nucleus accumbens opioids regulate flavor-based preferences in food consumption.

J D Woolley1, B S Lee, H L Fields.   

Abstract

Opioid signaling in the nucleus accumbens (NAcc) regulates feeding behavior, having particularly strong effects on consumption of highly palatable foods. Since macronutrient content may contribute to palatability, it is uncertain whether opioid regulation of food consumption is based primarily on its macronutrient content or its flavor per se. In order to isolate the effect of flavor, we manipulated opioid signaling in the NAcc in rats and quantified consumption of differently flavored but nutritionally identical pellets. When pellets of either flavor were presented alone, microinjection of d-Ala(2),N,Me-Phe(4),Gly-ol(5)-enkephalin (DAMGO (a mu opioid receptor (MOP) agonist)) into the NAcc increased consumption of pellets of both flavors equally. When both flavors of pellets were presented simultaneously, however, DAMGO in the NAcc selectively increased, while naltrexone (a non-selective opioid antagonist) in the NAcc selectively decreased, consumption of the more preferred flavor. Systemic naltrexone injection had no flavor specific effects, decreasing consumption of both flavors equally. Non-selective inactivation of NAcc neurons by local microinjection of muscimol (a GABA(A) agonist) increased consumption of both the more- and less-preferred flavors equally. These results indicate that opioid signaling directly regulates a subset of NAcc neurons that can selectively enhance consumption of preferred palatable foods based exclusively on flavor cues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049180     DOI: 10.1016/j.neuroscience.2006.06.067

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  32 in total

Review 1.  Cognitive and neuronal systems underlying obesity.

Authors:  Scott E Kanoski
Journal:  Physiol Behav       Date:  2012-01-12

Review 2.  Gustatory and reward brain circuits in the control of food intake.

Authors:  A J Oliveira-Maia; C D Roberts; S A Simon; M A L Nicolelis
Journal:  Adv Tech Stand Neurosurg       Date:  2011

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

4.  Amylin receptor signaling in the nucleus accumbens negatively modulates μ-opioid-driven feeding.

Authors:  Sarah K Baisley; Brian A Baldo
Journal:  Neuropsychopharmacology       Date:  2014-06-24       Impact factor: 7.853

5.  Disentangling pleasure from incentive salience and learning signals in brain reward circuitry.

Authors:  Kyle S Smith; Kent C Berridge; J Wayne Aldridge
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

6.  Imaging of brain dopamine pathways: implications for understanding obesity.

Authors:  Gene-Jack Wang; Nora D Volkow; Panayotis K Thanos; Joanna S Fowler
Journal:  J Addict Med       Date:  2009-03       Impact factor: 3.702

7.  High-fat intake induced by mu-opioid activation of the nucleus accumbens is inhibited by Y1R-blockade and MC3/4R- stimulation.

Authors:  Huiyuan Zheng; R Leigh Townsend; Andrew C Shin; Laurel M Patterson; Curtis B Phifer; Hans-Rudolf Berthoud
Journal:  Brain Res       Date:  2010-03-24       Impact factor: 3.252

8.  Opioid hedonic hotspot in nucleus accumbens shell: mu, delta, and kappa maps for enhancement of sweetness "liking" and "wanting".

Authors:  Daniel C Castro; Kent C Berridge
Journal:  J Neurosci       Date:  2014-03-19       Impact factor: 6.167

9.  Opioid receptor antagonism in the nucleus accumbens fails to block the expression of sugar-conditioned flavor preferences in rats.

Authors:  Sonia Y Bernal; Khalid Touzani; Meri Gerges; Yana Abayev; Anthony Sclafani; Richard J Bodnar
Journal:  Pharmacol Biochem Behav       Date:  2009-12-13       Impact factor: 3.533

Review 10.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.